首页> 美国卫生研究院文献>Vaccine: X >Immunogenicity and safety of concurrent or sequential administration of live attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) and measles-mumps-rubella vaccine in infants 9–12 months of age in the Philippines: A non-inferiority Phase 4 randomized clinical trial

【2h】

Immunogenicity and safety of concurrent or sequential administration of live attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) and measles-mumps-rubella vaccine in infants 9–12 months of age in the Philippines: A non-inferiority Phase 4 randomized clinical trial

机译：直播或连续施用的免疫原性和安全性衰减SA 14-14-2日本脑炎疫苗（CD-JEV）和婴儿9-12个月的麻疹-Mumps-Surbella疫苗：非劣势阶段4随机临床试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Vaccine: X
作者
Maria Rosario Capeding; Edison Alberto; Jodi Feser; Jessica Mooney; Yuxiao Tang; Susette A. Audet; Judy A. Beeler; Damon W. Ellison; Lei Zhang; G. William Letson; Kathleen M. Neuzil; Anthony A. Marfin;
展开▼
作者单位

展开▼
年(卷),期 2020(-1),-1
年度 2020
页码 -1
总页数 8
原文格式 PDF
正文语种
中图分类分子生物学;
关键词

相似文献

外文文献
专利

1. Immunogenicity and safety of measles-rubella vaccine co-administered with attenuated Japanese encephalitis SA 14-14-2 vaccine in infants aged 8 months in China: a non-inferiority randomised controlled trial [J] . Li Yan, Chu Susan Y., Yue Chenyan, The Lancet infectious diseases . 2019,第4期

机译：MEARLES-SUBELLA疫苗的免疫原性和安全性与减毒日本脑炎SA 14-14-2疫苗在中国8个月的婴儿中：非劣级随机对照试验
2. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age. [J] . Nolan T, Bernstein DI, Block SL, Pediatrics: Official Publication of the American Academy of Pediatrics . 2008,第3期

机译：麻疹，腮腺炎，风疹和水痘疫苗同时减毒活减毒流感疫苗对12至15个月大的婴儿的安全性和免疫原性。
3. Safety and Immunogenicity of Concurrent Administration of Live Attenuated Influenza Vaccine With Measles-Mumps-Rubella and Varicella Vaccines to Infants 12 to 15 Months of Age [J] . Colin Marchant, David I. Bernstein, Harry L. Keyserling, Pediatrics: Official Publication of the American Academy of Pediatrics . 2008,第3期

机译：麻疹，腮腺炎，风疹和水痘疫苗同时给药于12至15个月大的婴儿的减毒活疫苗的安全性和免疫原性
4. A double-blind, randomized phase II trial of thesafety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adults [C] . Shelly A. McNeil, Scott A. Halperin, Joanne M. Langley, Lancefield International Symposium on Streptococci and Streptococcal Diseases . 2006

机译：一种双盲，随机期II试验，对健康成人的26岁的26岁群体的疫苗疫苗
5. Immunogenicity and safety of a 2009 pandemic influenza A (H1N1) monovalent vaccine in Chinese infants aged 6–35 months: a randomized double‐blind controlled phase I clinical trial [O] . Yan‐Ping Li, Wei Li, Xiao‐Feng Liang, 2013

机译：2009年甲型H1N1大流行性流感单价疫苗在6-35 6月龄中国婴儿中的免疫原性和安全性：一项随机双盲对照的I期临床试验
6. Safety and immunogenicity of live-attenuated Japanese encephalitis SA 14-14-2 vaccine co-administered with measles vaccine in 9-month-old infants in Sri Lanka [O] . Wijesinghe Pushpa Ranjan, Abeysinghe M.R. Nihal, Yoksan Sutee, 2014

机译：减毒的日本脑炎SA 14-14-2疫苗与麻疹疫苗一起在斯里兰卡9个月大婴儿中的安全性和免疫原性

Immunogenicity and safety of concurrent or sequential administration of live attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) and measles-mumps-rubella vaccine in infants 9–12 months of age in the Philippines: A non-inferiority Phase 4 randomized clinical trial

著录项

相似文献

相关主题

期刊订阅